Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms232213751
Abstract: The treatment of young patients with Hodgkin lymphoma (HL) is often successful but a significant proportion of patients suffers from late toxicity. In the current era there are new opportunities for less toxic and more… read more here.
Keywords: navitoclax promising; hodgkin lymphoma; anti apoptotic; combination ... See more keywords